J.-L. Baulieu

529 total citations
20 papers, 396 citations indexed

About

J.-L. Baulieu is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, J.-L. Baulieu has authored 20 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in J.-L. Baulieu's work include Lymphatic System and Diseases (3 papers), Receptor Mechanisms and Signaling (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). J.-L. Baulieu is often cited by papers focused on Lymphatic System and Diseases (3 papers), Receptor Mechanisms and Signaling (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). J.-L. Baulieu collaborates with scholars based in France, United States and Sweden. J.-L. Baulieu's co-authors include Hakim Bouterfa, Kjell Öberg, Katherine Kacena, David Bushnell, Stanislas Pauwels, Mary Connolly, Rodney J. Hicks, Norman LaFrance, Yusuf Menda and Eric Van Cutsem and has published in prestigious journals such as Journal of Clinical Oncology, Life Sciences and Drug Metabolism and Disposition.

In The Last Decade

J.-L. Baulieu

20 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-L. Baulieu France 8 237 235 195 54 48 20 396
Tanweera Khan Sweden 6 163 0.7× 146 0.6× 119 0.6× 101 1.9× 94 2.0× 9 340
C.H.H. Schoenmakers Netherlands 8 221 0.9× 199 0.8× 159 0.8× 9 0.2× 64 1.3× 8 410
Margarida Rodrigues Austria 11 169 0.7× 172 0.7× 131 0.7× 84 1.6× 59 1.2× 33 386
Georgios S. Limouris Greece 11 119 0.5× 150 0.6× 95 0.5× 90 1.7× 48 1.0× 28 261
Dieter Hoersch Germany 9 238 1.0× 215 0.9× 170 0.9× 37 0.7× 15 0.3× 18 307
P H Lai Taiwan 10 51 0.2× 63 0.3× 81 0.4× 107 2.0× 59 1.2× 15 387
Kazutoshi Yokoyama Japan 11 53 0.2× 65 0.3× 48 0.2× 193 3.6× 18 0.4× 26 390
Reynolds Jc United States 7 266 1.1× 219 0.9× 193 1.0× 52 1.0× 68 1.4× 16 378
Patrick R. Bergevin United States 6 66 0.3× 116 0.5× 115 0.6× 5 0.1× 60 1.3× 12 335
Åke Thorson Sweden 5 456 1.9× 233 1.0× 382 2.0× 13 0.2× 88 1.8× 6 643

Countries citing papers authored by J.-L. Baulieu

Since Specialization
Citations

This map shows the geographic impact of J.-L. Baulieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-L. Baulieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-L. Baulieu more than expected).

Fields of papers citing papers by J.-L. Baulieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-L. Baulieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-L. Baulieu. The network helps show where J.-L. Baulieu may publish in the future.

Co-authorship network of co-authors of J.-L. Baulieu

This figure shows the co-authorship network connecting the top 25 collaborators of J.-L. Baulieu. A scholar is included among the top collaborators of J.-L. Baulieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-L. Baulieu. J.-L. Baulieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bushnell, David, Thomas M. O’Dorisio, M. Sue O’Dorisio, et al.. (2010). 90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide. Journal of Clinical Oncology. 28(10). 1652–1659. 225 indexed citations
4.
Prunier, Caroline, et al.. (2003). Radioprotection du personnel lors de traitements par OctreoTher$^{{\rm TM}}$: produit utilisant l'yttrium-90. Radioprotection. 38(3). 367–375. 1 indexed citations
5.
Vaillant, L., et al.. (2003). [Contribution of lymphoscintigraphy in the exploration of lymphedema in children].. PubMed. 28(5). 269–76. 10 indexed citations
6.
Bourlier, Pascal, B. Scotto, Véronique Eder, et al.. (2001). The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Nuclear Medicine Communications. 22(12). 1295–1304. 9 indexed citations
7.
Pichard‐Garcia, Lydiane, et al.. (2000). Human Hepatocytes in Primary Culture Predict Lack of Cytochrome P-450 3A4 Induction by Eletriptan In Vivo. Drug Metabolism and Disposition. 28(1). 51–57. 39 indexed citations
8.
Baulieu, J.-L., M.J. Santiago Ribeiro, F. Tranquart, et al.. (1999). Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using 123I-iodolisuride SPET. Nuclear Medicine Communications. 20(1). 77–84. 5 indexed citations
9.
Chalon, Sylvie, et al.. (1993). Comparison of two radioiodinated ligands of dopamine D2 receptors in animal models: Iodobenzamide and iodoethylspiperone. Life Sciences. 52(23). 1851–1860. 7 indexed citations
10.
Baulieu, J.-L., et al.. (1992). [Scintigraphic detection of gastrointestinal hemorrhage. Value and limitations].. PubMed. 46(4). 319–23. 2 indexed citations
11.
Chalon, Sylvie, et al.. (1990). Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: Synthesis and preliminary in vivo study. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 17(4). 389–395. 2 indexed citations
12.
Vaillant, L., et al.. (1990). [The current role of lymphoscintigraphy in the study of lymphedema of the limbs].. PubMed. 15(2). 152–6. 2 indexed citations
13.
Frangin, Y., Sylvie Chalon, F. Huguet, et al.. (1990). A new method to prepare no‐carrier‐added iodinated spirodecanone derivatives:1 application to dopaminergic and serotoninergic ligands. Journal of Labelled Compounds and Radiopharmaceuticals. 28(12). 1363–1373. 7 indexed citations
14.
Baulieu, J.-L., et al.. (1989). Factorial analysis of dynamic lymphoscintigraphy in lower limb lymphoedema. Nuclear Medicine Communications. 10(2). 109–120. 4 indexed citations
15.
Guilloteau, Denis, Sylvie Chalon, J.-L. Baulieu, et al.. (1988). Comparison of MIBG and monoamines uptake mechanisms: Pharmacological animal and blood platelets studies. European Journal of Nuclear Medicine and Molecular Imaging. 14-14(7-8). 341–4. 30 indexed citations
16.
Modigliani, E, J.A. Chayvialle, R. Cohen, et al.. (1988). Effect of a Somatostatin Analog (SMS 201-995) in Perfusion on Basal and Pentagastrin-Stimulated Calcitonin Levels in Medullary Thyroid Carcinoma. Hormone and Metabolic Research. 20(12). 773–775. 8 indexed citations
17.
Baulieu, J.-L., Denis Guilloteau, O. Le Floch, et al.. (1988). Therapeutic effectiveness of iodine-131 MIBG metastases of a nonsecreting paraganglioma.. PubMed. 29(12). 2008–13. 21 indexed citations
18.
Pape, A. Le, R. Barot-Ciorbaru, M Musset, et al.. (1986). An original method for submacroscopic metastases visualization in cases of cancer minimal residual disease.. PubMed. 40(10). 392–8. 12 indexed citations
19.
Guilloteau, Denis, et al.. (1986). Iodo carboxamidino-1 phenyl-4 piperazine un nouvel agent potentiel pour l’imagerie de la medullosurrenale: Comparaison avec la metaiodobenzylguadinine. International Journal of Nuclear Medicine and Biology. 12(6). 495–496. 2 indexed citations
20.
Maurage, C., et al.. (1984). A quantitative approach to gastrooesophageal reflux in children. Nuclear Medicine Communications. 5(11). 689–696. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026